As we at Budding Trends reported last week, the DEA is set to finally accept the recommendation of the U.S. Department of Health and Human Services (HHS) to reschedule marijuana from Schedule I to Schedule III under the...more
5/7/2024
/ Administrative Law Judge (ALJ) ,
Cannabis Products ,
Congressional Review Act ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Judicial Review ,
Legislative Agendas ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Notice of Proposed Rulemaking (NOPR) ,
OMB ,
Public Comment ,
Regulatory Agenda ,
Schedule I Drugs ,
State and Local Government
In a recent article, we noted that beverage industry giants have announced future plans to explore the CBD beverage market — a market that has an expected valuation of $1.4 billion by 2023....more
For several years, industry giants such as Coca-Cola, PepsiCo, and Anheuser-Busch have made waves announcing future plans to explore the CBD-beverage market. And last week, Nasdaq published an article on the future of...more
2/8/2022
/ Agribusiness ,
Beverage Manufacturers ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Federal Trade Commission (FTC) ,
Food & Drug Regulations ,
Food and Drug Administration (FDA) ,
Hospitality Industry ,
Labeling ,
Nasdaq ,
Regulatory Agenda